1. Home
  2. NVAX vs MD Comparison

NVAX vs MD Comparison

Compare NVAX & MD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • MD
  • Stock Information
  • Founded
  • NVAX 1987
  • MD 1979
  • Country
  • NVAX United States
  • MD United States
  • Employees
  • NVAX N/A
  • MD N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • MD Hospital/Nursing Management
  • Sector
  • NVAX Health Care
  • MD Health Care
  • Exchange
  • NVAX Nasdaq
  • MD Nasdaq
  • Market Cap
  • NVAX 1.3B
  • MD 1.2B
  • IPO Year
  • NVAX 1995
  • MD 1995
  • Fundamental
  • Price
  • NVAX $6.84
  • MD $13.17
  • Analyst Decision
  • NVAX Buy
  • MD Buy
  • Analyst Count
  • NVAX 5
  • MD 6
  • Target Price
  • NVAX $16.60
  • MD $16.67
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • MD 637.2K
  • Earning Date
  • NVAX 08-07-2025
  • MD 08-05-2025
  • Dividend Yield
  • NVAX N/A
  • MD N/A
  • EPS Growth
  • NVAX N/A
  • MD N/A
  • EPS
  • NVAX 2.97
  • MD N/A
  • Revenue
  • NVAX $1,254,962,000.00
  • MD $1,976,177,000.00
  • Revenue This Year
  • NVAX $56.85
  • MD N/A
  • Revenue Next Year
  • NVAX N/A
  • MD $3.26
  • P/E Ratio
  • NVAX $2.30
  • MD N/A
  • Revenue Growth
  • NVAX 25.92
  • MD N/A
  • 52 Week Low
  • NVAX $5.01
  • MD $6.69
  • 52 Week High
  • NVAX $17.81
  • MD $17.67
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • MD 39.72
  • Support Level
  • NVAX $6.54
  • MD $13.34
  • Resistance Level
  • NVAX $7.20
  • MD $13.68
  • Average True Range (ATR)
  • NVAX 0.28
  • MD 0.41
  • MACD
  • NVAX 0.06
  • MD -0.05
  • Stochastic Oscillator
  • NVAX 66.36
  • MD 14.37

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

Share on Social Networks: